Medication Assisted Treatment
Medication-Assisted Treatment (MAT)
The use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders. Research shows that when treating substance-use disorders, a combination of medication and behavioral therapies is most successful.
As part of a comprehensive treatment program, MAT has been shown to:
- Improve survival
- Increase retention in treatment
- Decrease illicit opiate use
- Decrease hepatitis and HIV seroconversion
- Decrease criminal activities
- Increase employment
- Improve birth outcomes with perinatal addicts
FDA approved Medications for Alcohol Dependence
- Naltrexone (ReVia®, Vivitrol®, Depade®) – http://dpt.samhsa.gov/medications/naltrexone.aspx
- Disulfiram (Antabuse®) – http://dpt.samhsa.gov/medications/disulfiram.aspx
- Acamprosate Calcium (Campral®) – http://dpt.samhsa.gov/medications/acamprosate.aspx
FDA approved Medications for Opioid Dependence
- Methadone – http://dpt.samhsa.gov/medications/methadone.aspx
- Buprenorphine (Suboxone® and Subutex®) – http://buprenorphine.samhsa.gov/about.html
- Naltrexone –
- http://dpt.samhsa.gov/medications/naltrexone.aspx
- An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People With Opioid Dependence https://store.samhsa.gov/shin/content/SMA12-4682/SMA12-4682.pdf
